Andy Lau

Andy Lau is an experienced professional in market access and business development within the healthcare sector. Currently serving as Associate Director for Market Access in Oncology and Immunology at HUTCHMED since August 2021, Andy previously held various positions at Merck Sharp & Dohme (Asia) Ltd from June 2008 to August 2021, including Market Access Manager, Business Development Lead, and Associate Business Unit Director roles in both Vaccines and Specialty Care. Andy's extensive background also encompasses senior management and strategic roles, contributing to significant knowledge in sales and alliance management.